Cargando…

Novel SLFN14 mutation associated with macrothrombocytopenia in a patient with severe haemorrhagic syndrome

BACKGROUND: Platelet-type bleeding disorder 20 (BDPLT20), as known as SLFN14-related thrombocytopenia, is a rare inherited thrombocytopenia (IT). Previously, only 5 heterozygous missense mutations in the SLFN14 gene have been reported. METHODS: A comprehensive clinical and laboratory examination of...

Descripción completa

Detalles Bibliográficos
Autores principales: Polokhov, Dmitrii, Fedorova, Daria, Ignatova, Anastasiya, Ponomarenko, Evgeniya, Rashevskaya, Elena, Martyanov, Alexey, Podoplelova, Nadezhda, Aleksenko, Maxim, Mersiyanova, Irina, Seregina, Elena, Poletaev, Aleksandr, Truchina, Ekaterina, Raykina, Elena, Plyasunova, Svetlana, Novichkova, Galina, Zharkov, Pavel, Panteleev, Mikhail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091655/
https://www.ncbi.nlm.nih.gov/pubmed/37041648
http://dx.doi.org/10.1186/s13023-023-02675-9
_version_ 1785023170492760064
author Polokhov, Dmitrii
Fedorova, Daria
Ignatova, Anastasiya
Ponomarenko, Evgeniya
Rashevskaya, Elena
Martyanov, Alexey
Podoplelova, Nadezhda
Aleksenko, Maxim
Mersiyanova, Irina
Seregina, Elena
Poletaev, Aleksandr
Truchina, Ekaterina
Raykina, Elena
Plyasunova, Svetlana
Novichkova, Galina
Zharkov, Pavel
Panteleev, Mikhail
author_facet Polokhov, Dmitrii
Fedorova, Daria
Ignatova, Anastasiya
Ponomarenko, Evgeniya
Rashevskaya, Elena
Martyanov, Alexey
Podoplelova, Nadezhda
Aleksenko, Maxim
Mersiyanova, Irina
Seregina, Elena
Poletaev, Aleksandr
Truchina, Ekaterina
Raykina, Elena
Plyasunova, Svetlana
Novichkova, Galina
Zharkov, Pavel
Panteleev, Mikhail
author_sort Polokhov, Dmitrii
collection PubMed
description BACKGROUND: Platelet-type bleeding disorder 20 (BDPLT20), as known as SLFN14-related thrombocytopenia, is a rare inherited thrombocytopenia (IT). Previously, only 5 heterozygous missense mutations in the SLFN14 gene have been reported. METHODS: A comprehensive clinical and laboratory examination of a 17-year-old female patient with macrothrombocytopenia and severe mucocutaneous bleeding was performed. Examination was carried out using standardized questionnaires to assess bleeding, high-throughput sequencing (Next Generation Sequencing), optical and fluorescence microscopy, flow cytometry with activation and analysis of intracellular calcium signaling of platelets, light transmission aggregometry and thrombus growth in the flow chamber. RESULTS: Analysis of the patient’s genotype revealed a previously undescribed c.655 A > G (p.K219E) variant in the hotspot of the SLFN14 gene. Immunofluorescence and brightfield examination of platelets in the smear showed heterogeneity in cells size, including giant forms over 10 μm (normal size 1–5) in diameter, with vacuolization and diffuse distribution of β(1)-tubulin and CD63. Activated platelets showed impaired contraction and shedding/internalization of GPIb. GP IIb/IIIa clustering was increased at rest and attenuated upon activation. Intracellular signalling study revealed impaired calcium mobilization upon TRAP 35.97 nM (reference range 180 ± 44) and CRP-XL 10.08 nM (56 ± 30) stimulation. Aggregation with ADP, collagen, TRAP, arachidonic acid and epinephrine was impaired in light transmission aggregometry; agglutination with ristocetin persisted. In the flow chamber with a shear rate of 400 s(-1) platelet adhesion to collagen and clot growth were impaired. CONCLUSION: The revealed disorders of phenotype, cytoskeleton and intracellular signaling explain the nature of SLFN14 platelet dysfunction and the patient’s severe hemorrhagic syndrome. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-023-02675-9.
format Online
Article
Text
id pubmed-10091655
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-100916552023-04-13 Novel SLFN14 mutation associated with macrothrombocytopenia in a patient with severe haemorrhagic syndrome Polokhov, Dmitrii Fedorova, Daria Ignatova, Anastasiya Ponomarenko, Evgeniya Rashevskaya, Elena Martyanov, Alexey Podoplelova, Nadezhda Aleksenko, Maxim Mersiyanova, Irina Seregina, Elena Poletaev, Aleksandr Truchina, Ekaterina Raykina, Elena Plyasunova, Svetlana Novichkova, Galina Zharkov, Pavel Panteleev, Mikhail Orphanet J Rare Dis Letter to the Editor BACKGROUND: Platelet-type bleeding disorder 20 (BDPLT20), as known as SLFN14-related thrombocytopenia, is a rare inherited thrombocytopenia (IT). Previously, only 5 heterozygous missense mutations in the SLFN14 gene have been reported. METHODS: A comprehensive clinical and laboratory examination of a 17-year-old female patient with macrothrombocytopenia and severe mucocutaneous bleeding was performed. Examination was carried out using standardized questionnaires to assess bleeding, high-throughput sequencing (Next Generation Sequencing), optical and fluorescence microscopy, flow cytometry with activation and analysis of intracellular calcium signaling of platelets, light transmission aggregometry and thrombus growth in the flow chamber. RESULTS: Analysis of the patient’s genotype revealed a previously undescribed c.655 A > G (p.K219E) variant in the hotspot of the SLFN14 gene. Immunofluorescence and brightfield examination of platelets in the smear showed heterogeneity in cells size, including giant forms over 10 μm (normal size 1–5) in diameter, with vacuolization and diffuse distribution of β(1)-tubulin and CD63. Activated platelets showed impaired contraction and shedding/internalization of GPIb. GP IIb/IIIa clustering was increased at rest and attenuated upon activation. Intracellular signalling study revealed impaired calcium mobilization upon TRAP 35.97 nM (reference range 180 ± 44) and CRP-XL 10.08 nM (56 ± 30) stimulation. Aggregation with ADP, collagen, TRAP, arachidonic acid and epinephrine was impaired in light transmission aggregometry; agglutination with ristocetin persisted. In the flow chamber with a shear rate of 400 s(-1) platelet adhesion to collagen and clot growth were impaired. CONCLUSION: The revealed disorders of phenotype, cytoskeleton and intracellular signaling explain the nature of SLFN14 platelet dysfunction and the patient’s severe hemorrhagic syndrome. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-023-02675-9. BioMed Central 2023-04-11 /pmc/articles/PMC10091655/ /pubmed/37041648 http://dx.doi.org/10.1186/s13023-023-02675-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Letter to the Editor
Polokhov, Dmitrii
Fedorova, Daria
Ignatova, Anastasiya
Ponomarenko, Evgeniya
Rashevskaya, Elena
Martyanov, Alexey
Podoplelova, Nadezhda
Aleksenko, Maxim
Mersiyanova, Irina
Seregina, Elena
Poletaev, Aleksandr
Truchina, Ekaterina
Raykina, Elena
Plyasunova, Svetlana
Novichkova, Galina
Zharkov, Pavel
Panteleev, Mikhail
Novel SLFN14 mutation associated with macrothrombocytopenia in a patient with severe haemorrhagic syndrome
title Novel SLFN14 mutation associated with macrothrombocytopenia in a patient with severe haemorrhagic syndrome
title_full Novel SLFN14 mutation associated with macrothrombocytopenia in a patient with severe haemorrhagic syndrome
title_fullStr Novel SLFN14 mutation associated with macrothrombocytopenia in a patient with severe haemorrhagic syndrome
title_full_unstemmed Novel SLFN14 mutation associated with macrothrombocytopenia in a patient with severe haemorrhagic syndrome
title_short Novel SLFN14 mutation associated with macrothrombocytopenia in a patient with severe haemorrhagic syndrome
title_sort novel slfn14 mutation associated with macrothrombocytopenia in a patient with severe haemorrhagic syndrome
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091655/
https://www.ncbi.nlm.nih.gov/pubmed/37041648
http://dx.doi.org/10.1186/s13023-023-02675-9
work_keys_str_mv AT polokhovdmitrii novelslfn14mutationassociatedwithmacrothrombocytopeniainapatientwithseverehaemorrhagicsyndrome
AT fedorovadaria novelslfn14mutationassociatedwithmacrothrombocytopeniainapatientwithseverehaemorrhagicsyndrome
AT ignatovaanastasiya novelslfn14mutationassociatedwithmacrothrombocytopeniainapatientwithseverehaemorrhagicsyndrome
AT ponomarenkoevgeniya novelslfn14mutationassociatedwithmacrothrombocytopeniainapatientwithseverehaemorrhagicsyndrome
AT rashevskayaelena novelslfn14mutationassociatedwithmacrothrombocytopeniainapatientwithseverehaemorrhagicsyndrome
AT martyanovalexey novelslfn14mutationassociatedwithmacrothrombocytopeniainapatientwithseverehaemorrhagicsyndrome
AT podoplelovanadezhda novelslfn14mutationassociatedwithmacrothrombocytopeniainapatientwithseverehaemorrhagicsyndrome
AT aleksenkomaxim novelslfn14mutationassociatedwithmacrothrombocytopeniainapatientwithseverehaemorrhagicsyndrome
AT mersiyanovairina novelslfn14mutationassociatedwithmacrothrombocytopeniainapatientwithseverehaemorrhagicsyndrome
AT sereginaelena novelslfn14mutationassociatedwithmacrothrombocytopeniainapatientwithseverehaemorrhagicsyndrome
AT poletaevaleksandr novelslfn14mutationassociatedwithmacrothrombocytopeniainapatientwithseverehaemorrhagicsyndrome
AT truchinaekaterina novelslfn14mutationassociatedwithmacrothrombocytopeniainapatientwithseverehaemorrhagicsyndrome
AT raykinaelena novelslfn14mutationassociatedwithmacrothrombocytopeniainapatientwithseverehaemorrhagicsyndrome
AT plyasunovasvetlana novelslfn14mutationassociatedwithmacrothrombocytopeniainapatientwithseverehaemorrhagicsyndrome
AT novichkovagalina novelslfn14mutationassociatedwithmacrothrombocytopeniainapatientwithseverehaemorrhagicsyndrome
AT zharkovpavel novelslfn14mutationassociatedwithmacrothrombocytopeniainapatientwithseverehaemorrhagicsyndrome
AT panteleevmikhail novelslfn14mutationassociatedwithmacrothrombocytopeniainapatientwithseverehaemorrhagicsyndrome